Лучшие больницы для «Liver Hemangioma» в Дубай, ОАЭ

The cost depends significantly on the treatment tier required. In India, an observation-and-diagnostic workup package (MRI, blood panel, MDT consultation, surveillance plan) costs approximately $2,500–$4,000 USD. Transarterial embolization (TAE) or thermal ablation (RFA/MWA) ranges from $3,500–$6,500 USD. Laparoscopic or robotic-assisted hepatic resection at JCI- and NABH-accredited centers such as Apollo Hospitals, Medanta, or Fortis typically costs $6,000–$9,500 USD, while complex open hepatic resection (major hepatectomy) is priced at $8,000–$12,000 USD. All-inclusive packages cover surgeon fees, anesthesia, operating room charges, hospital stay, standard medications, routine post-operative investigations, and one follow-up consultation. In the UAE (Dubai / Abu Dhabi), equivalent procedures cost approximately 50–70% more due to higher operational costs: diagnostic workup $5,500–$7,000 USD; TAE/ablation $8,000–$13,000 USD; laparoscopic/robotic resection $13,000–$19,000 USD; open major hepatectomy $18,000–$25,000 USD at JCI- and DHA/DOH-licensed centers such as Cleveland Clinic Abu Dhabi or Mediclinic City Hospital Dubai. Neither destination charges additional fees for operating room upgrade, and GAF Healthcare provides transparent, itemized cost estimates before any commitment is made. These figures do not include international airfare, travel insurance, or personal expenses.

The minimum in-country stay before you are medically cleared for international air travel depends entirely on which treatment you receive. If you undergo observation only (diagnostic workup plus MDT surveillance planning with no intervention), you are typically fit to fly within 1–2 days of the consultation, once test results are reviewed. After transarterial embolization (TAE), most patients are discharged within 24–48 hours and cleared for long-haul flight 7–10 days post-procedure (minimum 1–2 weeks in country). After radiofrequency or microwave ablation (RFA/MWA), the fit-to-fly window is 10–14 days post-procedure. After laparoscopic or robotic-assisted hepatic resection, the standard recommendation is 14–21 days post-surgery (2–3 weeks total in country), as wound assessment, drain removal, and a confirmatory imaging study (ultrasound or CT) must be completed before discharge clearance. After open hepatic resection (major hepatectomy via laparotomy), international flight is not recommended for a minimum of 4–6 weeks post-surgery due to the higher risk of deep vein thrombosis, wound complications, and bile collection that may require interventional drainage. Your operating surgeon at the GAF Healthcare partner hospital will issue a formal written fit-to-fly clearance letter that you will need for travel insurance purposes. For all surgical patients undertaking long-haul flights, compression stockings and pre-flight LMWH (low-molecular-weight heparin) prophylaxis are prescribed to mitigate DVT risk.

Success rates vary by treatment modality and are exceptionally high across the spectrum when performed at high-volume hepatobiliary centers. For observation/surveillance, the approach is considered successful in > 99% of patients with small (< 5 cm) asymptomatic hemangiomas, as these lesions carry a < 1% lifetime risk of complications and virtually zero malignant potential; structured surveillance reliably detects the minority that grow. Transarterial embolization (TAE) achieves symptomatic relief in 75–85% of patients and Kasabach-Merritt coagulopathy correction in > 90% of cases within 4 weeks, with a technical success rate of > 95%. Thermal ablation (RFA/MWA) delivers complete ablation in 88–95% of appropriately selected lesions ≤ 8 cm in a single session, with 5-year local recurrence rates below 5%. Laparoscopic and robotic-assisted hepatic resection achieve R0 resection (complete macroscopic and microscopic clearance) in > 98% of cases at expert centers; symptom resolution is reported in 95–98% of patients, with long-term hemangioma recurrence being exceedingly rare (< 1%) as resected hemangiomas do not recur at the operative site. Open hepatic resection carries similar R0 rates with perioperative mortality below 1% at tertiary hepatobiliary programs in India and the UAE. The overall composite success rate for all interventional forms of treatment (TAE + ablation + resection combined) at GAF Healthcare's partner hospitals is consistently reported above 95% in peer-reviewed outcome data. These figures are benchmarked against international standards published by the International Hepato-Pancreato-Biliary Association (IHPBA) and are achievable at accredited centers in both India and the UAE.